Potential for cost economies in guiding therapy in patients with metastatic breast cancer
- 1 July 1995
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 72 (1) , 174-177
- https://doi.org/10.1038/bjc.1995.297
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Chemotherapy of advanced breast cancer: outcome and prognostic factorsBritish Journal of Cancer, 1993
- The cost of breast cancer recurrencesBritish Journal of Cancer, 1992
- Objective measurement of therapeutic response in breast cancer using tumour markersBritish Journal of Cancer, 1991
- Assessment of four monoclonal antibodies as serum markers in breast cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical dataBritish Journal of Cancer, 1990
- Long-chain aliphatic fatty acids and phytanic acid simultaneously measured by dual-column capillary chromatography.Clinical Chemistry, 1989
- An evaluation of mucin-like carcinoma associated antigen (MCA) in breast cancerBritish Journal of Cancer, 1989
- Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapyEuropean Journal of Cancer and Clinical Oncology, 1989
- COMPARISON OF CA15-3 AND CARCINOEMBRYONIC ANTIGEN IN MONITORING THE CLINICAL COURSE OF PATIENTS WITH METASTATIC BREAST-CANCER1988
- Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, SwitzerlandCancer, 1977